GlassScriptPhysician profile
Arun Rajagopal
NPI 1942230602
$1,467.48
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901 · 2020: $503 · 2021: $43.83 · 2022: $19.58.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $337.95 | 2019-2020 | |
| Pfizer INC. | $162.58 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $145.36 | 2019-2020 | |
| Boston Scientific Corporation | $133.99 | 2019-2021 | |
| Nevro Corp. | $92.93 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $92.22 | 2019-2020 | |
| Zyla Life Sciences, INC. | $75.31 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.79 | 2019-2020 | |
| Medtronic USA, INC. | $58.03 | 2019-2020 | |
| Daiichi Sankyo INC. | $44.40 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.61 | 2019 | |
| Allergan, INC. | $41.09 | 2020 | |
| Shionogi INC | $36.82 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.24 | 2019 | |
| Scilex Pharmaceuticals INC. | $23.87 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.58 | 2022 | |
| Si-Bone, INC. | $17.52 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.24 | 2019 | |
| Assertio Therapeutics, INC. | $13.51 | 2020 | |
| Kaleo, INC. | $11.44 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Rajagopal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.